RxDoctor Payments Data

Michael Reed, MD

Cardiovascular Disease · Missoula, MTNPI 1346396967

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Edwards Lifesciences at 35.7% of the total. 2025 is the largest year on record at $2,332, 2.0 times the $1,156 reported in 2019.

$8,151in general payments, 2019–2025

Across 133 payments — averaging $61.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$3K
  • Medtronic$2K
  • Integra Lifesciences Corporation$892
  • Boston Scientific$866
  • Abbott$604
  • Shockwave Medical, Inc$169
  • plus $331 from 8 others
$629,132in research payments, 2019–2025

Across 85 payments — averaging $7401.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$617K
  • Medtronic$12K

What the payments were for

  • Speaking & faculty fees$1,00012%
  • Travel & lodging$2,95536%
  • Food & beverage$3,55144%
  • Education$240%
  • Other$6218%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,151 in reported general payments places this provider in the 80th percentile of 49 cardiovascular disease providers in Montana.

See all cardiovascular disease providers in Montana

Medicare billing

Part B allowed, 2024
$287,728
Medicare patients
988
Services billed
2,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor27$25,204
EliquisApixaban12$14,886
XareltoRivaroxaban11$13,867
ClopidogrelClopidogrel Bisulfate189$2,019
Prasugrel Hcl27$1,822
Atorvastatin Calcium136$1,650
Metoprolol Succinate66$929
Losartan Potassium25$288
Lisinopril26$212
Furosemide28$182
Nitroglycerin23$168
Isosorbide Mononitrate ErIsosorbide Mononitrate12$160
Amlodipine Besylate23$138
Metoprolol Tartrate14$129

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →